Project Description
Fuse Vectors are developing a novel, infinitely scalable, gene therapy manufacturing platform. Using this platform technology, Fuse Vectors aim to increase gene therapy manufacturing process speed, reduce cost-per-dose and produce safe gene therapies of the highest quality.
Fuse Vectors joined NOME in 2024.
